AbCellera
we have built an engine to generate first in class and best in class antibody medicines investments in technological capability can improve the productivity of drug development long term value creation comes from being able repeatedly deliver first in class products | AbCellera
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
4 of 14
Related slides by other companies
Morgan Stanley
Investor Conference
June 2021
and partnering and to deliver differentiated offering to corporate clients | Morgan Stanley
Absci
Investor Presentation
December 2023
reverse immunology platform unifies target and antibody discovery in a single enabling potential first in class | Absci
Oak Street Health
Mergers and Acquisitions
October 2021
| Oak Street Health
Crowdstrike
Investor Presentation
April 2023
falcon platform one agent to deliver all capabilities or | Crowdstrike
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Results
November 2023
Investor Presentation
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io